close save
crop image
Thu, Jun 21, 2018 | Last Updated 11:28 pm IST

Menu &Sections


Tata Consultancy Services Unveils First-of-its-Kind Clinical Trials Medication Management and Patient Engagement Platform

Tata Consultancy Services Unveils First-of-its-Kind Clinical Trials Medication Management and Patient Engagement Platform
data-page-url= 'http://www.apherald.com'

Tata Consultancy Services (TCS), (BSE: 532540, NSE: TCS) a leading global IT services, consulting and business solutions organization, has launched Connected Clinical Trials (CCT), an innovative Software as a Service (SaaS) platform that enables pharmaceutical companies to significantly transform patient engagement in clinical trials and improve the efficiency and accountability of the clinical supply process.

 Tata Consultancy Services Unveils First-of-its-Kind Clinical Trials Medication Management and Patient Engagement Platform

CCT is part of TCS’ Advanced Drug Development (ADD) suite that offers a wide range of cloud based clinical services, including Clinical Data Management, Metadata Management, Pharmacovigilance, and Data Analytics and Insights. ADD is powered by a cognitive engine called ‘Decision Fabric’ that enables automation of complex business processes. ADD leverages the best of cloud architecture and intuitive user experience design in compliance with “good clinical practice” quality guidelines (GCP) and privacy regulations.


TCS’ Connected Clinical Trials Platform provides a scalable cloud solution that addresses patients’ needs through various clinical trial stages, including enrolment, treatment and follow-up stages.


CCT includes four modules:

  • CCT Tracking: utilizes scanners to track all medication kit transactions at the site to prevent dispensing errors, ensuring that the correct medication kit is given to the right patient at the right time.

  • CCT Communication: provides patient-specific, real-time notifications, dosing instructions, tutorial videos via smart phones, enables continuous adverse event data collection, and facilitates personalized patient support in medication dosing and study procedures.

  • CCT Label: employs patientspecific and easily readable all-in-one electronic drug labels in the patient's preferred language.

  • CCT Adherence: enables registration and verification of individual intake via sensor enabled medication packages (smart packages) to eliminate guesswork for medication intake, ensuring that the right pill is taken at the right time.


Janssen Research & Development, LLC collaborated with Tata Consultancy Services (TCS) to build-out TCS’ Connected Clinical Trials (CCT) platform, as part of the Janssen integrated Smart Trial and Engagement Platform. 


The CCT platform has also been tested and proven in a live set-up at TCS’ state-of-the-art User Experience labs with global patient and site advisory boards. This was conducted in collaboration with the Center for Information and Study on Clinical Research Participation (CISCRP), an independent non-profit organization dedicated to educating and informing the public and patients about clinical research.


I believe the CCT platform will help us to accurately track patient adherence to the study protocol, while also helping us to more easily and efficiently manage trial supplies at the site,”said Harpreet Isha Monga, B.Pharm, M.Pharm, PHD, Clinical Research Coordinator and Neuropsychiatric Rater at Neuro-Pain Medical Center Inc.


TCS’ Connected Clinical Trials will enablelife sciences companies to harness digital technologies to engage with patients more effectively during clinical trials and significantly improve adherence to medical dosage during thosetrials,” said Debashis Ghosh, President - Life Sciences, Healthcare, Government, and Energy Business Group, TCS.TCS' strong domain and technology expertise makes it well positioned to offer advanced platform solutions catering to specific needs of the industry and we are excited to have Janssen as our first customer on CCT.


About TCS Life Sciences

TCS Life Sciences provides top global Life Sciences organisations full service offerings in IT, Consulting, KPO, Infrastructure, and Engineering Services, as well as digital solutions using Mobility, Big Data, Analytics, and Cloud. TCS’ rich industry experience, domain expertise and global footprint allows for a seamless partnership with its Life Sciences customers to help them advance clinical trial efficiencies, accelerate drug discovery, accentuate manufacturing productivity and amplify sales and marketing effectiveness. In addition, TCS has a dedicated Life Sciences Innovation Lab, which ensures that its customers have the tools and innovative solutions they need to solve complex business challenges.


About Tata Consultancy Services Ltd (TCS)

Tata Consultancy Services is an IT servicesconsulting and business solutions organization that delivers real results to global business, ensuring a level of certainty no other firm can match. TCS offers a consulting-led, integrated portfolio of ITBPSinfrastructureengineering and assurance services. This is delivered through its unique Global Network Delivery Model™, recognized as the benchmark of excellence in software development. A part of the Tata group, India’s largest industrial conglomerate, TCS has over 389,000 of the world’s best-trained consultants in 46 countries. The company generated consolidated revenues of US $17.6 billion for year ended March 31, 2017 and is listed on the BSE (formerly Bombay Stock Exchange) and the NSE (National Stock Exchange) in India.


For more information, please visit us at www.tcs.com.


To stay up-to-date on TCS news in North America, follow @TCS_NA. For TCS global news, follow @TCS_News.


TCS media contacts


 Email: ashish.babu@tcs.com

 Phone: +31611531246


 Email: peter.devery@tcs.com Phone: +44 20 3155 2421 


 Email: h.ramachandra@tcs.com | shamala.p@tcs.com Phone: +91 22 6778 9078 | +91 22 6778 9081

 USA / Canada

 Email: b.trounson@tcs.com Phone: +1 646 313 4594

 Asia Pacific

 Email: neerja.jetley@tcs.com Phone: +65-90295944

 Australia and New Zealand

 Email: Darren.rudd@tcs.com

 Phone: +61 488 403 013

 Latin America

 Email: martin.karich@tcs.com

 Phone: +569 6170 9013


 Email: mattias.afgeijerstam@tcs.com

 Phone: +46723989188


 Email: douglas.foote@tcs.com

 Phone: +81 80 2115 0989

5/ 5 - (1 votes)
Add To Favourite
More from author
About the author

What you have to remember is that it isn't you who is being personally rejected. It simply means that a particular agent wasn't interested in what you wrote.